Replimune Announces $100 Million Private Placement Financing
Replimune(REPL) Newsfilter·2024-06-13 12:30- Led by a life-sciences focused institutional investor, with participation from Redmile Group, RTW Investments, Boxer Capital and other institutional investors - - Proceeds enable full commercial scale up to support a potential launch in 2H 2025 - Pursuant to the terms of the securities purchase agreement, Replimune will issue and sell to the investors an aggregate of 5,668,937 shares of its common stock ("Common Stock") at a price of $8.82 per share of Common Stock and pre-funded warrants to purchase 5,66 ...